Workflow
骨骼健康益生菌潜力巨大,政策推动行业规范化发展 头豹词条报告系列
Tou Bao Yan Jiu Yuan·2024-11-27 13:06

Investment Rating - The report indicates a positive investment outlook for the bone health probiotic industry, highlighting significant growth potential driven by increasing consumer awareness and demand for health products [3][35]. Core Insights - The bone health probiotic market is experiencing rapid expansion due to heightened consumer health awareness and the effectiveness of probiotics in improving bone metabolism and density [3][35]. - The industry has evolved through three stages: the initial phase of foundational research, the regulatory phase promoting standardization, and the current phase characterized by rapid growth and innovation [10][20]. - The aging population in China is driving demand for bone health solutions, with probiotics emerging as a natural and effective intervention [14][25]. Industry Definition - Probiotics are live microorganisms that can confer health benefits to the host when consumed in adequate amounts, particularly in improving bone health through mechanisms involving the gut microbiome [4][27]. Industry Classification - The bone health probiotic industry can be categorized based on the types of conditions they address, including osteoporosis, osteoarthritis, and periodontal diseases [6][7]. Industry Characteristics - The development of the bone health probiotic industry in China has progressed from a nascent stage to a high-growth phase, driven by increasing market demand and technological advancements [10][20]. Market Size - The market size for bone health probiotics grew from 91.88 billion to 148.83 billion from 2018 to 2023, with a compound annual growth rate (CAGR) of 10.13%. It is projected to reach 200.04 billion by 2028, with a CAGR of 5.98% [35]. Policy Overview - Recent policies have strengthened the regulatory framework for probiotics, enhancing product quality and market competitiveness for domestic brands [13][31]. Development History - The industry has transitioned through distinct phases, with significant advancements in research and product development occurring since 2016, leading to increased patent applications and market activity [15][20]. Upstream Analysis - The upstream segment focuses on the research and development of probiotic strains, which is crucial for ensuring a steady supply of innovative products [22][26]. Midstream Analysis - The midstream segment involves the processing and manufacturing of probiotic products, with local companies increasingly investing in this area to meet growing consumer demand [28][30]. Downstream Analysis - The downstream segment encompasses the retail and distribution of bone health probiotic products, which are increasingly sought after by consumers, particularly among the aging population [32][33].